Search
Research outputs
VCd versus VRd in Newly Diagnosed Multiple Myeloma: Matched Real-World Analysis from the Balkan Myeloma Study Group (BMSG)
[2025]
Kastritis, Efstathios; ...; Bila, Jelena S. 
; ...; Cvetković, Zorica P. ; Marković, Olivera B. ; ...; Sretenović, Aleksandra M.; ...; (broj koautora 24)
Prognostic impact of response-adjusted ISS score in Multiple Myeloma
[2021]
Mitrović, Marko; Bukumirić, Zoran M. ; Sretenović, Aleksandra M.; Miketić, Ivana; Bila, Jelena S.
The Use of PET/CT in Radiotherapy Planning in Young Women with Hodgkin's Lymphoma
[2019]
Mitric-Askovic, Milana; Licina, Jelena T ; Ivanov, Olivera ; Baucal, Milutin D
Prognostic Significance of Cereblon Expression in Patients With Multiple Myeloma
[2016]
Bila, Jelena ; Sretenovic, Aleksandra; Jelicic, Jelena ; Tošić, Nataša ; Glumac, Irena ; Fekete, Marija Dencic; Antić, Darko ; Todorović, Milena ; Marković, Olivera ; Milojevic, Zoran;
Radojković, Milica ; Trajković, Goran ; Puric, Mila; Pavlović, Sonja ; Mihaljević, Biljana ;
; Trajković, Goran ; Puric, Mila; Pavlović, Sonja ; Mihaljević, Biljana ; Treating Multiple Myeloma: 10 Years of Experience at the National Cancer Research Center of Serbia [2025]
Kojic, Andrijana; Puric, MilaAnalyses of Treatment Outcome According to Age in Patients With Chronic Myeloid Leukemia Receiving Front-line Imatinib Therapy
[2017]
Ćojbašić, Irena ; Mačukanović Golubović, Lana ; Vučić, Miodrag ; Tijanić, Ivan
Ultra-high-risk prognostic significance of double and triple hit myeloma
[2021]
Bila, Jelena S. ; Mitrović, Marko; Bukumirić, Zoran M. ; Jovanović, Jelica V.; Denčić-Fekete, Marija ; Sretenović, Aleksandra M.; Jeličić, Jelena J. ; Perić, Teodora; Mihaljević, Biljana S. ; Antić, Darko A.
Disease Characteristics and Treatment Outcomes of Myeloma Patients Under 50 Years of Age: An Analysis of the Balkan Myeloma Study Group
[2025]
Fotiou, Despina; ...; Bila, Jelena S. ; ...; Sretenović, Aleksandra; Marković, Olivera ; ...; Cvetković, Zorica P. ; ...; (broj koautora 23)
Lighthouse: melflufen, daratumumab, and dexamethasone versus daratumumab in relapsed/refractory multiple myeloma refractory to an imid and a proteasome inhibitor or with ≥3 prior lines of therapy
[2023]
Mateos, Maria-Victoria; Szarejko, Monika; Bila, Jelena S. ; Schjesvold, Fredrik; Spicka, Ivan; Maisnar, Vladimir; Jurczyszyn, Artur; Grudeva-Popova, Zhanet; Hajek, Roman; Usenko, Hanna;
Thuresson, Marcus; Norin, Stefan; Jarefors, Sara; Richardson, Paul; Pour, Ludek;
Filters
By type
- 20